Discover advanced Multiple Myeloma Treatment and Procedures at Liv Hospital. We offer stem cell transplants, immunotherapy, and personalized care pathways.

Treatment and Procedures

Advanced Care & Stem Cell Therapies

Multiple Myeloma

The landscape of Multiple Myeloma treatment has undergone a revolutionary transformation in the last decade. What was once considered a rapidly progressing disease is now manageable for many patients as a chronic condition, thanks to the introduction of novel agents, immunotherapies, and advanced stem cell transplantation techniques.

At Liv Hospital, our goal goes beyond just symptom management. We aim for "deep remission" , a state where no cancer cells can be detected in the body. By combining the latest FDA-approved drug protocols with our world-class bone marrow transplant infrastructure, we offer international patients access to the same high standards of care found in top US medical centers, often with faster accessibility.

This guide details the strategic phases of myeloma treatment, from the initial "induction" therapy to the life-saving potential of stem cell transplantation.

The Three Phases of Treatment

Multiple Myeloma

Treating multiple myeloma is rarely a one-step process. It typically follows a strategic timeline designed to reduce the tumor burden, eliminate residual cells, and maintain remission.

  1. Induction Therapy: Rapidly killing the bulk of cancer cells using a combination of drugs.
  2. Consolidation (Stem Cell Transplant): Using high-dose chemotherapy followed by a stem cell rescue to deepen the response.
  3. Maintenance Therapy: Long-term, low-dose treatment to prevent the cancer from returning.

Induction Therapy: The First Line of Defense

Multiple Myeloma

For most newly diagnosed patients, treatment begins with "Induction Therapy." This usually involves a "triplet" or "quadruplet" regimen, a cocktail of three or four different types of drugs working together to attack the cancer from different angles.

Common agents used in these combinations include:

  • Proteasome Inhibitors (e.g., Bortezomib/Velcade): These drugs block the cellular machinery that breaks down proteins, causing myeloma cells to fill up with waste and die.
  • Immunomodulatory Drugs (e.g., Lenalidomide/Revlimid): These oral medications harness your immune system to recognize and destroy cancer cells.
  • Corticosteroids (e.g., Dexamethasone): High doses of steroids are surprisingly effective at killing myeloma cells and reducing inflammation.
  • Monoclonal Antibodies (e.g., Daratumumab): These are lab-made proteins that bind specifically to markers on the surface of myeloma cells, flagging them for destruction by the immune system.

Autologous Stem Cell Transplantation (ASCT)

Multiple Myeloma

For eligible patients, an Autologous Stem Cell Transplant remains the "gold standard" of care in multiple myeloma treatment. It is not a surgery, but rather a complex procedure that allows doctors to use chemotherapy doses that are 5 to 10 times higher than normal.

Why is it necessary? 

Myeloma cells are sensitive to chemotherapy, but so is healthy bone marrow. Standard doses of chemotherapy are limited by the damage they cause to your blood production. By collecting your stem cells before the high-dose chemotherapy, we can "rescue" your bone marrow afterward.

The Procedure at Liv Hospital:

  1. Mobilization & Harvest: We use medication to move stem cells from your bone marrow into your bloodstream, where they are collected via a machine (apheresis) and frozen.
  2. Conditioning: You receive a high dose of chemotherapy (usually Melphalan) to wipe out the myeloma cells in your marrow.
  3. Infusion: The stored stem cells are thawed and infused back into your vein like a blood transfusion.
  4. Engraftment: Over the next 10-14 days, these cells travel to the bone marrow and begin producing new, healthy blood cells.

Immunotherapy and CAR T-Cell Therapy

Multiple Myeloma

For patients whose myeloma has relapsed (returned) or is refractory (stopped responding) to standard treatments, Liv Hospital offers access to cutting-edge immunotherapies.

CAR T-Cell Therapy: This is one of the most exciting advancements in cancer care. It involves taking the patient's own T-cells (immune cells), genetically modifying them in a lab to recognize a specific protein on myeloma cells (BCMA), and infusing them back into the patient. These "supercharged" T-cells then hunt down and destroy the cancer.

Bispecific T-cell Engagers (BiTEs): These are "bridge" drugs that attach to both a cancer cell and a T-cell, pulling them together so the immune system can attack the cancer directly.

Radiation and Supportive Procedures

Multiple Myeloma

While drug therapies treat the whole body (systemic), local treatments are often needed to manage specific complications:

  • Radiation Therapy: High-energy beams are used to target specific bone lesions that are causing severe pain or are at risk of fracture. It is also used if a tumor is pressing on the spinal cord.
  • Vertebroplasty/Kyphoplasty: Minimally invasive procedures where bone cement is injected into a collapsed vertebra to stabilize the spine and relieve pain instantly.
  • Bone Strengthening Agents: Drugs like bisphosphonates (Zometa) or denosumab are given monthly to strengthen bones and prevent fractures.

Managing Relapsed or Refractory Myeloma

It is common for multiple myeloma to return eventually. This is called a relapse. When this happens, our team at Liv Hospital is prepared with "Second-Line" and "Third-Line" protocols.

  • Switching Drug Classes: If the cancer becomes resistant to one drug, we switch to another (e.g., from Bortezomib to Carfilzomib).
  • Second Transplant: In some cases, a second autologous transplant or an allogeneic transplant (from a donor) may be considered.
  • Clinical Trials: We actively participate in international research, giving patients access to new drugs before they are widely available.

Why Choose Liv Hospital for Myeloma Treatment?

Treating multiple myeloma requires more than just a doctor; it requires an ecosystem.

  • Multidisciplinary Tumor Boards: Your case is discussed weekly by a team of hematologists, radiation oncologists, and pathologists.
  • Infection Control: Our stem cell transplant unit is equipped with HEPA-filtered positive pressure rooms to protect you when your immune system is weakest.
  • Holistic Support: We integrate pain management, nutritional counseling, and physical therapy into your treatment plan to maintain your quality of life.

Who Can Benefit?

acute-lymphocytic-leukemia

Acute Lymphocytic Leukemia: Understanding Rapidly Progressing Blood Cancer

Aplastic Anemia

Precision care for a rare disorder: expert testing, tailored treatment, safer follow‑up.

Bone marrow failure

Restoring immunity, oxygenation, and life at the cellular level

Graft Disease

What Are Stem Cells? A Guide to Regenerative Medicine

Graft versus host

Biomarkers, prophylaxis, and next-generation approaches to GvHD care

leukemia

Multidisciplinary expertise for complex leukemia cases

Longevity

Longevity focused on proactive health strategies, preventive care, and optimizing vitality for a longer,...

Lymphocytic Leukemia

Comprehensive lymphocytic leukemia care, from diagnosis through survivorship.

Lymphoma

Understanding cancers of the lymphatic and immune system.

Multiple Myeloma

Understanding plasma cell cancer and bone marrow health.

Myelodysplastic Syndrome

Understanding bone marrow failure and blood cell production.

Myelofibrosis

Understanding bone marrow scarring and blood cell disruption.

Myelogenous Leukemia

Understanding rapid white blood cell growth and bone marrow.

Sickle Cell

Breakthrough treatments and dedicated support for the Sickle Cell community

Stem Cell Transplant

Curative pathways and expert protocols for successful Stem Cell Transplantation

Thalassemia

Comprehensive care and genetic insights for managing Thalassemia effectively.

Frequently Asked Questions

Is a stem cell transplant dangerous?

Like any major medical procedure, it carries risks, primarily related to infection while the immune system is recovering. However, autologous transplants (using your own cells) have a very low mortality rate (less than 1-2%) in experienced centers like Liv Hospital.

Will I lose my hair during treatment?

It depends on the drugs used. The high-dose chemotherapy (Melphalan) used during a stem cell transplant almost always causes hair loss. However, many modern induction therapies (like Revlimid or Velcade) do not typically cause significant hair loss.

How long does the treatment take?

Induction therapy typically lasts 3-4 months. If you proceed to a stem cell transplant, the hospital stay is usually 2-3 weeks, followed by a recovery period of 2-3 months at home or in a hotel near the hospital. Maintenance therapy can continue for years.

What is the success rate of treatment?

While "cure" is a difficult term in myeloma, "remission" is very achievable. With modern triplet therapies and transplantation, the median survival has more than tripled in recent years, with many patients living 10 years or more with good quality of life.

Can I receive CAR T-Cell therapy at Liv Hospital?

CAR T-Cell therapy is a highly specialized and regulated treatment. Availability depends on specific approvals and your eligibility. Our specialists can evaluate if you are a candidate for this or other advanced immunotherapies during your consultation.